Amalgamated Financial Corp. AMAL
49.89 USD -0.54 (-1.07%)
At closeNov 3, 2026, 4:01 PM EST
49.89 0.00 0.00%
After hours · Nov 3, 4:01 PM ET
49.70 Day range 50.47
26.61 52-week range 52.30
- YTD
- +55.76%
- 1 year
- +81.35%
Analyst view
Consensus: buy
Buy
Price target (mean) 56.00 +12.2% upside
Now 49.89
- Target (low)
- 53.00
- Target (mean)
- 56.00
- Target (high)
- 60.00
Ratings (0m) 3 2 buy · 1 hold · 0 sell
- Strong buy2
- Buy0
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.08 | 1.08 – 1.09 | 0.99 | +9.4% | 98.67M | +12.2% | 3 |
| Next quarter | 1.05 | 1.04 – 1.06 | 0.80 | +30.8% | 96.57M | +5.7% | 3 |
| Current year | 4.13 | 4.12 – 4.13 | 3.64 | +13.4% | 387.60M | +15.3% | 3 |
| Next year | 4.67 | 4.64 – 4.70 | 4.13 | +13.1% | 409.64M | +5.7% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 3, 2026 | Raymond James | Initiated | — | Outperform |
| Jul 27, 2026 | Piper Sandler | Maintained | Neutral | Neutral |
| Jul 24, 2026 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Jun 26, 2026 | Piper Sandler | Maintained | Neutral | Neutral |
| Apr 27, 2026 | Piper Sandler | Maintained | Neutral | Neutral |
| Jul 29, 2024 | Keefe, Bruyette & Woods | Reiterated | Outperform | Outperform |
| Jun 27, 2024 | JP Morgan | Maintained | Overweight | Overweight |
| Apr 26, 2024 | Piper Sandler | Reiterated | Overweight | Overweight |
| Apr 5, 2024 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Apr 4, 2024 | JP Morgan | Maintained | Overweight | Overweight |
| Jan 5, 2024 | JP Morgan | Maintained | Overweight | Overweight |
| Dec 12, 2023 | JP Morgan | Upgrade | Neutral | Overweight |
| Dec 1, 2023 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Oct 31, 2023 | JP Morgan | Maintained | Neutral | Neutral |
| Oct 5, 2023 | JP Morgan | Maintained | Neutral | Neutral |
| Aug 2, 2023 | JP Morgan | Maintained | Neutral | Neutral |
| Jun 29, 2023 | JP Morgan | Maintained | Neutral | Neutral |
| May 1, 2023 | Keefe, Bruyette & Woods | Maintained | — | Outperform |
| Apr 6, 2023 | Keefe, Bruyette & Woods | Maintained | — | Outperform |
| Apr 6, 2023 | JP Morgan | Maintained | — | Neutral |
| Jan 31, 2023 | Keefe, Bruyette & Woods | Maintained | — | Outperform |
| Dec 20, 2022 | Piper Sandler | Maintained | — | Overweight |
| Jul 1, 2022 | JP Morgan | Maintained | — | Neutral |
| Nov 2, 2021 | Raymond James | Maintained | — | Outperform |
| Nov 1, 2021 | Barclays | Maintained | — | Overweight |
| Sep 23, 2021 | Piper Sandler | Maintained | — | Overweight |
| Mar 23, 2021 | JP Morgan | Downgrade | Overweight | Neutral |
